Latest medical treatment strategies for venous thromboembolism
- 11 June 2007
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 8 (9), 1221-1233
- https://doi.org/10.1517/14656566.8.9.1221
Abstract
Anticoagulant therapy with unfractionated heparin (UFH) followed by warfarin prevents thrombus extension, reduces the risk of recurrent thrombosis and prevents death in patients with venous thromboembolism (VTE). Low-molecular-weight heparin (LMWH) has replaced UFH as the preferred initial anticoagulant therapy for VTE because it is as effective and safe as UFH, but does not require laboratory monitoring and is less likely to cause immune thrombocytopenia and osteoporosis. More recently, fondaparinux has been shown to be an effective and safe alternative to LMWH and several new parenteral anticoagulants are being evaluated. The most important unmet need in the anticoagulant management of VTE is a replacement for warfarin. New oral anticoagulants that selectively target individual steps in the coagulation cascade have been shown to be effective for the long-term treatment of VTE in Phase II and III trials and are likely to become available in the near future.Keywords
This publication has 81 references indexed in Scilit:
- Oral Anticoagulants in DevelopmentDrugs, 2006
- New anticoagulantsBlood, 2005
- Initial Treatment of Venous ThromboembolismCirculation, 2004
- Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary EmbolismCirculation, 2004
- Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems Comparison with heparin and low-molecular-weight heparinThrombosis and Haemostasis, 2004
- The statin warsThe Lancet, 2003
- Pharmacokinetics and anticoagulant properties of the factor VIIa-tissue factor inhibitor recombinant Nematode Anticoagulant Protein c2 following subcutaneous administration in manThrombosis and Haemostasis, 2003
- The Pharmacokinetics of Fondaparinux Sodium in Healthy VolunteersClinical Pharmacokinetics, 2002
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986